Chronic alcohol consumption increases oxidative stress and then induces hepatic inflammation. However, a disturbance of lipid homeostasis, i.e., stimulation of lipogenesis, inhibition of β-oxidation of fatty acids is also observed in the development of alcoholic steatohepatitis (ASH/AFLD). From this study, we found that Tau supplementation can lower liver triacylglycerol levels in alcohol-fed rats via the downregulation of FAS and ME gene expressions and the upregulation of PPAR-α gene expression. Additionally, Tau supplementation also decreases TBARS values in sera and livers which result in lower hepatic TNF-α level and MMP-9 activity, thus decreasing liver inflammation. In conclusion, Tau supplementation regulates lipid metabolism and alleviates anti-inflammation of livers in chronic alcohol consumption.